Literature DB >> 28736433

Diabetes mellitus: Complex interplay between metformin, AKI and lactic acidosis.

Connie M Rhee1, Kamyar Kalantar-Zadeh1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28736433      PMCID： PMC5922434          DOI： 10.1038/nrneph.2017.105

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.

Authors:  Willemijn L Eppenga; Arief Lalmohamed; Arjen F Geerts; Hieronymus J Derijks; Michel Wensing; Antoine Egberts; Peter A G M De Smet; Frank de Vries
Journal:  Diabetes Care       Date:  2014-05-19       Impact factor: 19.112

2.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

3.  Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.

Authors:  Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephron       Date:  2016-10-20       Impact factor: 2.847

4.  Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.

Authors:  Szu-Chun Hung; Yu-Kang Chang; Jia-Sin Liu; Ko-Lin Kuo; Yu-Hsin Chen; Chih-Cheng Hsu; Der-Cherng Tarng
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-17       Impact factor: 32.069

5.  Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.

Authors:  Florent F Richy; Meritxell Sabidó-Espin; Sandra Guedes; Frank A Corvino; Ulrike Gottwald-Hostalek
Journal:  Diabetes Care       Date:  2014-05-30       Impact factor: 19.112

6.  Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!

Authors:  Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112

7.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.

Authors:  Samira Bell; Bassam Farran; Stuart McGurnaghan; Rory J McCrimmon; Graham P Leese; John R Petrie; Paul McKeigue; Naveed Sattar; Sarah Wild; John McKnight; Robert Lindsay; Helen M Colhoun; Helen Looker
Journal:  BMC Nephrol       Date:  2017-05-19       Impact factor: 2.388

9.  Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.

Authors:  Paul J Connelly; Mike Lonergan; Enrique Soto-Pedre; Louise Donnelly; Kaixin Zhou; Ewan R Pearson
Journal:  Diabetes Obes Metab       Date:  2017-07-05       Impact factor: 6.577

10.  Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register.

Authors:  Nils Ekström; Linus Schiöler; Ann-Marie Svensson; Katarina Eeg-Olofsson; Junmei Miao Jonasson; Björn Zethelius; Jan Cederholm; Björn Eliasson; Soffia Gudbjörnsdottir
Journal:  BMJ Open       Date:  2012-07-13       Impact factor: 2.692
  10 in total
  6 in total

1.  Clarifying the relationship between metformin, acute kidney injury and lactic acidosis.

Authors:  Samira Bell; Enrique Soto-Pedre; Paul Connelly; Shona Livingstone; Ewan Pearson
Journal:  Nat Rev Nephrol       Date:  2017-12-13       Impact factor: 28.314

2.  Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.

Authors:  Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2017-12-13       Impact factor: 28.314

3.  Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational Study.

Authors:  Yiling Zhou; Miye Wang; Si Wang; Nan Li; Shengzhao Zhang; Siqi Tang; Qingyang Shi; Yuliang Zhao; Jingwen Li; Yuping Zeng; Huan Song; Haoming Tian; Shuangqing Li; Sheyu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-12       Impact factor: 5.555

Review 4.  Metformin: A Novel Weapon Against Inflammation.

Authors:  Bo Bai; Haibo Chen
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

5.  A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment.

Authors:  Zhi Xiang Du; Fang Qun Chang; Zi Jian Wang; Da Ming Zhou; Yang Li; Jiang Hua Yang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

Review 6.  Significance of Metformin Use in Diabetic Kidney Disease.

Authors:  Daiji Kawanami; Yuichi Takashi; Makito Tanabe
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.